Gregory Oakes's Insider Trades & SAST Disclosures
Gregory Oakes's most recent trade in Landos Biopharma Inc was a trade of 54,454 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 29, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gregory Oakes.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Landos Biopharma Inc | Gregory Oakes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 54,454 | 54,454 | - | - | Restricted Stock Unit | |
| Landos Biopharma Inc | Gregory Oakes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 475,300 | 475,300 | - | - | Employee Stock Option (right to buy) | |
| Landos Biopharma Inc | Gregory Oakes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2022 | 1,677,251 | 1,677,251 | - | - | Employee Stock Option (right to buy) | |
| First Wave BioPharma Inc | Gregory Oakes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 34,482 | 34,482 | - | - | Stock option (right to buy) | |
| First Wave BioPharma Inc | Gregory Oakes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 41,237 | 41,237 | - | - | Options (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges